BlackRock’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-125,660
Closed -$14.6M 5189
2020
Q2
$14.6M Buy
+125,660
New +$14.5M ﹤0.01% 2973

Other funds holding ZBH

BlackRock's ZBH Position: Q1 2026 in Review

BlackRock reduced its Zimmer Biomet (ZBH) stake by 1.7% in Q1 2026, selling an estimated $24.2M and leaving 15,340,806 shares worth $1.39B. The position accounts for 0.02% of the portfolio, ranked #537.

BlackRock first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.37B in Q2 2021. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • BlackRock held 15,340,806 shares of Zimmer Biomet worth $1.39B as of Q1 2026.
  • BlackRock sold 263,704 Zimmer Biomet shares in Q1 2026, an estimated $24.2M.
  • Zimmer Biomet made up 0.02% of BlackRock's portfolio in Q1 2026, its #537 holding.
  • BlackRock first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's Zimmer Biomet position peaked at $3.37B in Q2 2021.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.